TP-102 compassionate uses cases presented at ECCMID 2023

TP-102 compassionate uses cases presented at ECCMID 2023

5 Mai 2023 | News

Last month Technophage team attended ECCMID 2023, and together with the clinical team from Israel, we have presented the results from two cases of compassionate use carried out in Israel, under the supervision of Dra. Michal Deckel. – Case study 1 showed a...
New phase of the Bio-Hub mobilizing agenda

New phase of the Bio-Hub mobilizing agenda

4 Abr 2023 | Press release

Technophage is one of the co-promoters of the Bio-Hub Agenda – a National R&D Platform for Production, Commercialization and Distribution of Innovative Biopharmaceuticals – together with LxBio – Pharmaceuticals, VectorB2B – Drug...
Technophage is hiring a laboratory technician

Technophage is hiring a laboratory technician

27 Mar 2023 | Careers

TechnoPhage is currently looking for a laboratory technician to join our clinical research team. The candidate should have a professional or vocational technical course and will be asked to perform several laboratory tecniques, while maintain the lab environment,...
Technophage attends 13th Annual World ADC 2023

Technophage attends 13th Annual World ADC 2023

15 Mar 2023 | Events

Technophage’s Head of Neurosciences Raquel Ferreira is currently in London at the 13th Annual World ADC 2023, learning with the best, about the latest products, projects and technologies on the field. If you are interested in ADCs you can still join us and have...
Technophage patent portfolio

Technophage patent portfolio

15 Mar 2023 | News

TechnoPhage is currently working on several projects in different therapeutic areas, such as infection, ophthalmology, or neuroscience, among which numerous patents have been placed throughout the years. Did you know that the total number of ‘live’ patents...